In progress …
- Bank of biological samples and clinical data (CHUM)
- Global database for high-risk PSTTs, ETTs and GTNs. Investigator: Dr. B Hanckok
- International database of low-risk gestational trophoblastic diseases. A ISSTD project. Investigator: Dr. B. You, Lyon, France
- Is chemotherapy always needed for choriocarcinoma management where disease is apparently completely excised? Objectives: To determine the outcome of patients with pathological diagnosis of gestational choriocarcinoma followed by spontaneous hCG normalization without chemotherapy. Investigators: France, Belgium, Liege, Denmark, United Kingdom, Netherlands, Sweden, Brazil, Ireland, Switzerland, Boston, Chicago, Quebec.
- Retrospective Outcomes Analysis Comparing Single Agent With Multiagent Chemotherapy For Low Risk Gestational Trophoblastic Neoplasia Investigators: Dr. P. Hoskins, Vancouver Centre, British Columbia Cancer Agency and Dr. A. Kumar, Fraser Valley Cancer Centre, British Columbia Cancer Agency.
- Tumor phenotyping and immune microenvironment of gestational trophoblastic tumours: preclinical study of the expression of PDL1, CD73 and the A2A receptor. Investigators: Dr Y. Dabi (France), Dr Ph. Sauthier, Dr C. Touboul (France), Dr V. Samouëlian.
- International FIGO database. Objectives: To evaluate performance of the FIGO 2000 risk scoring system in terms of treatment response and outcome. Investigators: Boston, Chicago, Venezuela, United Kingdom, Brazil, Quebec, Philipines, France, Netherlands, Hong Kong
Completed
- GOG 174
- GOG 275
- SOGC/GOC Canadian guidelines on GTD/GTN. Investigators: SOGC/GOC/SCC Policy and Practice Guidelines Committee, Dr. L. Eiriksson Gynecologic Oncology, McMaster University, Dr. E. Dean, Gynecologic Oncology, University of Manitoba
- International research project managed by Dr E. Kohorn of Yale in order to determine the factors involved in the management of trophoblastic diseases, GOC GTD/GTN Survey, Patient and Professional Satisfaction Questionnaire.
Modified on 12/23/2023